PHARMA UNITED
The computed 12-month bankruptcy probability of PHARMA UNITED is 0.6% (low). The 2024 annual accounts show equity of €126k and a net result of €71k. Equity is growing by ~30.1% per year across the filed fiscal years. Its solvency ranks better than 95% of 2537 sector peers (fiscal year 2024). The company has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €126k |
| Net result | €71k |
| Better than sector | 95% |
| Active | 10 yrs |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 99.5% | 56.2% | |
| Net result | €71k | €19k | |
| Equity | €126k | €43k | |
| Gross operating margin | €71k | €37k | |
| Total assets | €126k | €93k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | - |
| Net profit | €71k |
| Cash flow | - |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €126k |
| Equity | €126k |
| Debt | €585 |
| of which ≤ 1y | €585 |
| of which > 1y | - |
| Working capital | €126k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 215.76 |
| Quick ratio | 215.76 |
| Working capital ratio | 99.5% |
| Solvency | 99.5% |
| Debt / equity | 0.00 |
| Long-term debt ratio | - |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | 56.0% |
| ROE | 56.3% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €126k |
| Current assets | 29/58 | €126k |
| Amounts receivable within one year | 40/41 | €118k |
| Cash & bank | 54/58 | €8k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €126k |
| Equity | 10/15 | €126k |
| Contributions / capital | 10/11 | €693k |
| Accumulated profits (losses) | 14 | €-567k |
| Amounts payable | 17/49 | €585 |
| Amounts payable within one year | 42/48 | €585 |
| Trade debts payable within one year | 44 | €229 |
| Income statement | ||
| Gross operating margin | 9900 | €71k |
| Operating result | 9901 | €71k |
| Financial charges | 65 | €7 |
| Result before taxes | 9903 | €71k |
| Net result for the period | 9904 | €71k |
| Result to be appropriated | 9905 | €71k |
-
Current25-01-2023 → present
2 events
- 19-01-2026 Appointed· Director
- 25-01-2023 Appointed· Director
Former directors (5)
-
RED CODE NVLegal entityDirector· perm. rep.: Christophe ReynaertState Gazette act 23034017 (09-03-2023)Former- → 25-01-2023
-
Former- → 25-01-2023
-
SIBL-INCLegal entityDirector· perm. rep.: PIERS Bruno Francois GinetteState Gazette act 23034017 (09-03-2023)Former- → 16-05-2022
-
Former- → 16-05-2022
-
Former- → 16-05-2022
| NACE primary | Advertising & market research(73300) |
| Legal form | Public limited company(014) |
| Incorporation | 07-01-2016 |
| Status | Active |
| Postal code | 2960 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11019B0225/00W000 | Flanders | 501 m² | 1 · 158 m² | 11.9 m · 3 fl. |
| 11333B0351/00R000 | Flanders | 485 m² | 1 · 117 m² | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
19-01-2026 1 director appointed, 1 resigning
- SUYKERBUYK Katleen, Bestuurder
- Besloten vennootschap "AMBIXX", Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Besloten vennootschap \u0022AMBIXX\u0022",
"address": null,
"birth_date": null
},
"evidence_quote": "De algemene vergadering besluit de huidige bestuurders, hierna vermeld, ontslag te geven uit hun functie: Besloten vennootschap \u0022AMBIXX\u0022, met zetel te 2960 Brecht, Kapelstraat 15, ingeschreven in het rechtspersonenregister te Antwerpen, afdeling Antwerpen onder nummer BE0651.692.322, met als vaste v",
"discharge_granted": false
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "SUYKERBUYK Katleen",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0651692322",
"name": "Besloten vennootschap \u0022AMBIXX\u0022",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Wordt benoemd tot niet-statutaire enige bestuurder, Besloten vennootschap \u0022AMBIXX\u0022, met zetel te 2960 Brecht, Kapelstraat 15, ingeschreven in het rechtspersonenregister te Antwerpen, afdeling Antwerpen onder nummer BE0651.692.322, met als vaste vertegenwoordiger de heer COOREMAN Laurent Raymond Alin"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0645.674.560",
"name_full": "PHARMA UNITED",
"legal_form": "NV"
}
}09-03-2023 Registered office moved from Merchtem to Brecht
- Kwekelaarstraat 3, 1785 Merchtem → Kapelstraat 15, 2960 Brecht
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Brecht",
"region": "Vlaams Gewest",
"street": "Kapelstraat",
"country": "BE",
"postcode": "2960",
"box_number": null,
"street_number": "15"
},
"old_address": {
"city": "Merchtem",
"region": "Vlaams Gewest",
"street": "Kwekelaarstraat",
"country": "BE",
"postcode": "1785",
"box_number": null,
"street_number": "3"
},
"effective_date": "2023-01-25",
"evidence_quote": "Met ingang van 25/01/2023 wordt de maatschappelijke zetel verplaatst van Kwekelaarstraat 3, 1785 Merchtem naar Kapelstraat 15, 2960 Brecht"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0645.674.560",
"name_full": "PHARMA UNITED",
"legal_form": "NV"
}
}20-08-2019 Capital increase of €50,225 to €692,500
- €642.275 → €692.500
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 50225.0,
"currency": "EUR",
"after_eur": 692500.0,
"delta_eur": 50225.0,
"before_eur": 642275.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2017-04-13",
"evidence_quote": "De vergadering beslist om het kapitaal van de vennootschap te verhogen met een bedrag van 50.225,00 euro om het te brengen van 642.275,00 euro op 692.500,00 euro",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0645.674.560",
"name_full": "PHARMA UNITED",
"legal_form": "NV"
}
}09-11-2016 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2016-10-24",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0645.674.560",
"name_full": "PHARMA UNITED",
"legal_form": "NV"
},
"signature_regime": "joint_two",
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}08-04-2016 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": true,
"seat_change": false,
"object_change": false,
"effective_date": "2016-03-25",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0645.674.560",
"name_full": "UNITED PHARMA",
"legal_form": "NV"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}18-01-2016 Incorporation of a new NV
Technical details
{
"kind": "oprichting",
"seat": "Kwekelaarstraat 3, 1785 Brussegem",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": {
"kbo": "0440.165.412",
"name": "RED CODE"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": "0440.165.412",
"holder_org_name": "RED CODE",
"contribution_type": "cash",
"amount_paid_in_eur": 100000,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 15000,
"amount_subscribed_eur": 100000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "VAN WAEYENBERGE Patrick Guido Magda Jozef",
"niss": null,
"address": "1000 Brussel, Anderlechtsesteenweg 185/B5"
},
"share_class": null,
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": null,
"amount_paid_in_eur": 0,
"holder_person_name": "VAN WAEYENBERGE Patrick Guido Magda Jozef",
"is_subscriber_only": false,
"n_shares_subscribed": 0,
"amount_subscribed_eur": 0,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 100000,
"subject_company": {
"kbo": "0645.674.560",
"name_full": "UNITED PHARMA",
"legal_form": "NV"
},
"initial_directors": [],
"incorporation_date": "2015-01-04",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | PHARMA UNITED |